Growth Metrics

Alvotech (ALVO) Common Equity (2020 - 2025)

Alvotech filings provide 6 years of Common Equity readings, the most recent being -$412.8 million for Q3 2025.

  • On a quarterly basis, Common Equity fell 20.09% to -$412.8 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$412.8 million, a 20.09% decrease, with the full-year FY2024 number at -$412.8 million, up 55.73% from a year prior.
  • Common Equity hit -$412.8 million in Q3 2025 for Alvotech, down from -$173.3 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of -$135.6 million in Q4 2021 to a low of -$932.5 million in Q4 2023.
  • Median Common Equity over the past 5 years was -$412.8 million (2024), compared with a mean of -$467.9 million.
  • Biggest five-year swings in Common Equity: soared 84.36% in 2021 and later crashed 316.2% in 2022.
  • Alvotech's Common Equity stood at -$135.6 million in 2021, then plummeted by 316.2% to -$564.4 million in 2022, then tumbled by 65.21% to -$932.5 million in 2023, then soared by 55.73% to -$412.8 million in 2024, then changed by 0.0% to -$412.8 million in 2025.
  • The last three reported values for Common Equity were -$412.8 million (Q3 2025), -$173.3 million (Q2 2025), and -$412.8 million (Q1 2025) per Business Quant data.